Raanana, Israel - Polyrizon Ltd. (NASDAQ:PLRZ), a biotech firm in the development stage, has filed a divisional patent application in Israel for its Trap & Target (NYSE:TGT) (T&T) platform technology.

Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced the filing of a ...

People in England with a severe dust mite allergy are set to be offered a daily pill on the NHS, it has been announced today (Thursday January 30), as part of a big shake up.

Officials installed the stations as part of a pilot program on Monday at the Boston and Springfield RMVs, as well as MassDOT ...

The city has installed Narcan kits at public locations after receiving them as a donation from Mothers for Awareness and ...

The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

The new capability includes clean room for compounding, fill-finish and release of non-sterile nasal sprays, and dry powders. In addition, Kenox is w ...

Chris Cavallo & Daughter Cristina Cavallo Co Founder's of The Robin Foundation Walk for Lives The Robin Foundation The Robin ...

MDR Certification Strengthens Resyca’s Leadership in Soft Mist Drug-Device Combination Products ENSCHEDE, NL / ACCESS ...

The FDA has approved the use of Spravato, an antidepressant nasal spray, as a standalone treatment for depression in the U.S. Sue Varma discusses why she supports the use of the drug and how it may ...

PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT) - Commercial capabilities build out in process, with proposed launch in PSVT ...